Retracted, A. 2017. EFFICACY AND SAFETY OF ADALIMUMAB VERSUS INFLIXIMAB IN PATIENTS SUFFERED FROM MODERATE TO SEVERE ACTIVE ULCERATIVE COLITIS. Asian Journal of Pharmaceutical and Clinical Research. 10, 3 (Mar. 2017), 300–307.